RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2005; 94(02): 460-462
DOI: 10.1055/s-0037-1614772
DOI: 10.1055/s-0037-1614772
Case Report
Reactive thrombocytosis associated with a pheochromocytoma
Authors
Weitere Informationen
Publikationsverlauf
Received: 09. Dezember 2004
Accepted after major revision: 12. Mai 2005
Publikationsdatum:
15. Dezember 2017 (online)
-
References
- 1 Gordon DL, Atamian SD, Brooks MH. et al. Fever in pheochromocytoma. Arch Intern Med 1992; 152: 1269-72.
- 2 Quesenberry PJ, McGrath HE, Williams ME. et al. Multifactor stimulation of megakaryocytopoiesis: effects of interleukin. Exp Hematol 1991; 19: 35-41.
- 3 Bruno E, Hoffman R.. Effect of interleukin 6 on in vitro human megakaryocytopoiesis: its interaction with other cytokines. Exp Hematol 1989; 17: 1038-43.
- 4 Kaser A, Brandacher G, Steurer W. et al. Interleukin- 6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001; 98: 2720-5.
- 5 Tefferi A, Ho TC, Ahmann GJ. et al. Plasma interleukin- 6 and C-reactive protein levels in reactive versus clonal thrombocytosis. Am J Med 1994; 97: 374-8.
- 6 Hollen CW, Henthorn J, Koziol JA. et al. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol 1991; 79: 286-90.
- 7 Hsu HC, Lee YM, Tsai WH. et al. Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome. Oncology 2002; 63: 64-9.
- 8 Cerutti A, Custodi P, Duranti M. et al. Thrombopoietin levels in patients with primary and reactive thrombocytosis. Br J Haematol 1997; 99: 281-4.
- 9 Hsu HC, Tsai WH, Jiang ML. et al. Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis. J Lab Clin Med 1999; 134: 392-7.
- 10 Cerutti A, Custodi P Mduranti. et al. Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant. Clin Lab Haematol 1999; 21: 271-5.
- 11 Ishibashi T, Kimura H, Shikama Y. et al. Interleukin- 6 is a potent thrombopoietic factor in vivo in mice. Blood 1989; 74: 1241-4.
- 12 Herodin F, Mestries JC, Janodet D. et al. Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiationinduced bone marrow depression in baboons. Blood 1992; 80: 688-95.
- 13 D'Hondt V, Humblet Y, Guillaume T. et al. Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study. Blood 1995; 85: 2347-53.
- 14 van Gameren MM, Willemse PH, Mulder NH. et al. Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 1994; 84: 1434-41.
- 15 Gordon MS, Nemunaitis J, Hoffman R. et al. A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia. Blood 1995; 85: 3066-76.
- 16 Salahuddin A, Rohr-Kirchgraber T, Shekar R. et al. Interleukin-6 in the fever and multiorgan crisis of pheochromocytoma. Scand J Infect Dis 1997; 29: 640-2.
- 17 Minetto M, Dovio A, Ventura M. et al. Interleukin-6 producing pheochromocytoma presenting with acute inflammatory syndrome. J Endocrinol Invest 2003; 26: 453-7.
- 18 Fukumoto S, Matsumoto T, Harada S. et al. Pheochromocytoma with pyrexia and marked inflammatory signs: a paraneoplastic syndrome with possible relation to interleukin-6 production. J Clin Endocrinol Metab 1991; 73: 877-81.
- 19 Suzuki K, Miyashita A, Inoue Y. et al. Interleukin- 6-producing pheochromocytoma. Acta Haematol 1991; 85: 217-9.
- 20 Shimizu C, Kubo M, Takano K. et al. Interleukin-6 (IL-6) producing phaeochromocytoma: direct IL-6 suppression by non-steroidal anti-inflammatory drugs. Clin Endocrinol 2001; 54: 405-10.
- 21 Takagi M, Egawa T, Motomura T. et al. Interleukin- 6 secreting phaeochromocytoma associated with clinical markers of inflammation. Clin Endocrinol 1997; 46: 507-9.
- 22 Frost RA, Nystrom GJ, Lang CH.. Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity. Am J Physiol Endocrinol Metab 2004; 286: E809-817.
- 23 Rontgen P, Sablotzki A, Simm A. et al. Effect of catecholamines on intracellular cytokine synthesis in human monocytes. Eur Cytokine Netw 2004; 15: 14-23.
- 24 Liao J, Keiser JA, Scales WE. et al. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol 1995; 268: R896-901.
- 25 Zhou D, Kusnecov AW, Shurin MR. et al. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic- pituitary-adrenal axis. Endocrinology 1993; 133: 2523-30.
- 26 Burger A, Benicke M, Deten A. et al. Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2001; 281: H14-21.
- 27 van Gool J, van Vugt H, Helle M. et al. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopathol 1990; 57: 200-10.
- 28 Kanauchi H, Mimura Y, Hiki N. et al. Catecholamine and cytokine response to laparoscopic adrenalectomy in patients with pheochromocytoma. Biomed Pharmacother 2000; 54 (Suppl. 01) 191s-193s.